In several studies [37,54,55,56], metformin administration in type 2 diabetic patients led to an increase of serum fibroblast growth factor 21 (FGF21) concentrations; a hormone increased in muscle wasting and degeneration. This evidence concerns the gene FGF21 and type 2 diabetes mellitus.